Invivyd Inc. • IVVD

Capital at risk.

About Invivyd Inc.
Ticker
info
IVVD
Trading on
info
NASDAQ
ISIN
info
US46187W1071
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
-
Headquarters
info
1601 Trapelo Road, Waltham, MA, United States, 02451
Employees
info
99
Website
info
https://invivyd.com
Invivyd, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's pipeline includes PEMGARDA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate, which is in preclinical studies for the prevention or treatment of COVID-19; and Adintrevimab that is in phase 2/3 clinical trials for the prevention and treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$116M
P/E ratio
info
-
EPS
info
-$1.19
Dividend Yield
info
0.00%
Beta
info
0.64
Forward P/E ratio
info
4.91
EBIDTA
info
$-146M
Ex dividend date
info
-
Price & volume
Market cap
info
$116M
Average daily volume
info
3.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
4.91
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
3.17
Price to book
info
2.15
Earnings
EPS
info
-$1.19
EPS estimate (current quarter)
info
-$0.01
EPS estimate (next quarter)
info
$0.01
EBITDA
info
$-146M
Revenues (TTM)
info
$36.7M
Revenues per share (TTM)
info
$0.31
Technicals
Beta
info
0.64
52-week High
info
$2.74
52-week Low
info
$0.36
50-day moving average
info
$0.67
200-day moving average
info
$0.83
Short ratio
info
3.33
Short %
info
11.15%
Management effectiveness
ROE (TTM)
info
-122.69%
ROA (TTM)
info
-57.84%
Profit margin
info
0.00%
Gross profit margin
info
$34.2M
Operating margin
info
-149.70%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
120M
Float
info
49.8M
Insiders %
info
41.18%
Institutions %
info
65.96%
Analyst Insights & forecasts
info

67% Buy

33% Hold

0% Sell

Based on information from 3 analysts.

Average price target

info
$4.93
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.40
-$0.37
-8.11%
Q2 • 24Missed
-$0.51
-$0.35
-45.71%
Q3 • 24Missed
-$0.15
-$0.10
-50.00%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$13.8M
$-18.4M
-133.45%
Q4 • 24
$11.3M
$-16.3M
-144.10%
Q1 • 25
-18.21%
-11.68%
7.98%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$130M
$62M
47.85%
Q4 • 24
$104M
$49.6M
47.81%
Q1 • 25
-19.90%
-19.98%
-0.10%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-37.6M
$0M
$0.1M
$-37.6M
Q4 • 24
$-21.1M
$-0.1M
$0M
$-21.3M
Q1 • 25
-43.82%
-2,980.00%
-87.01%
-43.43%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Invivyd Inc. share?
Collapse

Invivyd Inc. shares are currently traded for undefined per share.

How many shares does Invivyd Inc. have?
Collapse

Invivyd Inc. currently has 120M shares.

Does Invivyd Inc. pay dividends?
Collapse

No, Invivyd Inc. doesn't pay dividends.

What is Invivyd Inc. 52 week high?
Collapse

Invivyd Inc. 52 week high is $2.74.

What is Invivyd Inc. 52 week low?
Collapse

Invivyd Inc. 52 week low is $0.36.

What is the 200-day moving average of Invivyd Inc.?
Collapse

Invivyd Inc. 200-day moving average is $0.83.

Who is Invivyd Inc. CEO?
Collapse

The CEO of Invivyd Inc. is -.

How many employees Invivyd Inc. has?
Collapse

Invivyd Inc. has 99 employees.

What is the market cap of Invivyd Inc.?
Collapse

The market cap of Invivyd Inc. is $116M.

What is the P/E of Invivyd Inc.?
Collapse

The current P/E of Invivyd Inc. is null.

What is the EPS of Invivyd Inc.?
Collapse

The EPS of Invivyd Inc. is -$1.19.

What is the PEG Ratio of Invivyd Inc.?
Collapse

The PEG Ratio of Invivyd Inc. is null.

What do analysts say about Invivyd Inc.?
Collapse

According to the analysts Invivyd Inc. is considered a buy.